CBD Will Be US FDA’s ‘One’ Lawful Hemp Compound, House Appropriators Anticipate

Reference in report accompanying House Appropriation Committee bill for FDA FY2023 budget isn’t binding and wasn’t appropriators’ first mention of agency’s response to de-scheduling hemp as a controlled substance. But their ’ statement was more pointed than in previous appropriation reports.